Subscribe to our Email Alerts


Dr Jose Iglesias MD

Clinical Adviser (Oncology)

Dr Jose Iglesias has over 30 years’ experience in the pharmaceutical industry, primarily focused on the clinical development of new oncology drugs and has held senior executive leadership roles with many of the leading oncology pharmaceutical companies including GSK, Eli Lilly, AMGEN, Abraxis and Celgene. During this time, he has designed and developed clinical trials for all phases of clinical trials (Phase 1-to-Phase 4), including three oncology Phase 3 registration trials that involved over 2,000 patients. Dr Iglesias was responsible for the Phase 3 development of Abraxane in pancreatic cancer, lung cancer and metastatic breast cancer. As a result of this work, Abraxane became the new worldwide standard of care of the treatment of advanced pancreatic cancer.